https://www.thebodypro.com/article/fda-recommends-approval-atazanavir-new-protease-inhibitor
Atazanavir (Reyataz)

The FDA Recommends the Approval of Atazanavir, a New Protease Inhibitor

Also: BMS Lipid Studies on Atazanavir Presented to the FDA

    Jules Levin

    Seattle Treatment Education Project

    Seattle Treatment Education Project